Targeted agents: how can we improve the outcome in biliary tract cancer?

Παρόμοια τεκμήρια

• Preclinical activity of EGFR and MEK1/2 inhibitors in the treatment of biliary tract carcinoma
  ανά: Cavalloni, Giuliana, κ.ά.
  Έκδοση: (2016)
• Endoscopic Guided Biliary Drainage: How Can We Achieve Efficient Biliary Drainage?
  ανά: Kedia, Prashant, κ.ά.
  Έκδοση: (2013)
• Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas
  ανά: Pignochino, Ymera, κ.ά.
  Έκδοση: (2010)
• Malaria: How Are We Doing and How Can We Do Better?
  ανά: Rosenthal, Philip J., κ.ά.
  Έκδοση: (2019)
• Molecular targeted therapy for biliary tract malignancy: defining the target
  ανά: Fisher, Sarah B., κ.ά.
  Έκδοση: (2012)